Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2591-2017Class II

Merge PACS software. Merge PACS (Picture Archiving Communication System) is designed and marketed for soft...

Merge Healthcare Incorporated / initiated 2017-05-08 / Terminated / root cause: software

Merge Healthcare, Inc. began a recall of Merge PACS software. Merge PACS (Picture Archiving Communication System) is designed and marketed for soft copy reading, communication, and storage of studies... on . FDA classified it as Class II and gives the reason as "When cut lines are shown on an image, the lines may go from being vertical and then shift to horizontal causing confusion to the physician. This may cause a misdiagnosis". As of , the recall status on record is Terminated, and MDM tags the root cause as software.

Recall record

Recall number
Z-2591-2017
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Merge Healthcare Incorporated
Product
Merge PACS software. Merge PACS (Picture Archiving Communication System) is designed and marketed for soft copy reading, communication, and storage of studies produced by digital modalities, including digital mammography
Product code
LLZ System, Image Processing, Radiological
Reason for recall
When cut lines are shown on an image, the lines may go from being vertical and then shift to horizontal causing confusion to the physician. This may cause a misdiagnosis.
Root cause tag
software
FDA root cause
Software design (manufacturing process)
Action
Merge sent an Urgent Medical Device Recall letter dated May 5, 2017, to all affected customers. Customers were instructed to be aware of the following workaround: Do not have the simple close study red x icon available in the reading physicians toolbars. This will force them to set status on close which also presents the warning Not all images have been reviewed, do you want to set status anyway and close study or continue reviewing unviewed images? YOUR RESPONSE TO THIS NOTIFICATION IS REQUIRED By replying to this notification, you will be taking the necessary steps to ensure that the issue listed in this document will be resolved. Please reply using the enclosed form and the return addressed envelope. Customers with questions were instructed to send an email to [email protected]. For questions regarding this recall call 877-741-6369.
Quantity in commerce
47 sites have the potentially affected versions
Distribution
Nationwide Distribution
Product codes and lots
Versions 7.0.2.1, 7.0.2.2, 7.0.2.3, 7.0.2.3 P1, and 7.0.2.3 P2

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2591-2017
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2591-2017Class IITerminatedVoluntary: Firm initiated